Inflection Point Acquisition Corp. VIII (IPHX)

Price—Loading quote

AI: Fair-priced

Verified identity and pre-combination SPAC statusIPHX is the Nasdaq-listed Class A ordinary share of Inflection Point Acquisition Corp. VIII, SEC CIK 0002146310. As of October 27, 2026, it remains a pre-business-combination SPAC without a publicly identified acquisition target.

FACTS: The September 30, 2026 Form 8-K identifies the Cayman Islands issuer, SEC file number 001-43464, and three Nasdaq Global Market securities: IPHX (Class A ordinary shares, $0.0001 par value), IPHXU (units containing one Class A share and one-third of a warrant), and IPHXW (redeemable warrants). The issuer's official corporate website independently identifies Inflection Point VIII as Nasdaq: IPHX and Michael Blitzer as its chairman. Its investor-relations navigation did not display a dedicated VIII page when checked on October 27, 2026; the issuer's SEC filings and company-issued announcements therefore provide the primary VIII-specific disclosures. The company completed its IPO on August 31, 2026. INFERENCE: Based on reviewed issuer filings and announcements available through October 27, no signed business-combination agreement, announced target, shareholder approval or completed merger was identified. Transactions involving other Inflection Point SPACs, including IPFX and IPXG, must not be attributed to IPHX.

Trust backing and redemption economicsThe latest verified post-IPO audited trust balance is $287,500,000, equivalent to $10.00 per public share as of August 31, 2026. Against the October 27 observed price of $9.83, this represents a $0.17 discount, or approximately 1.73% gross potential appreciation to the initial trust value.

FACTS: The audited August 31, 2026 balance sheet, filed September 4, reports $287.5 million in trust and 28.75 million redeemable public Class A shares. The June 30 Form 10-Q, filed September 28, predates the IPO and is not a newer post-IPO trust measurement. The contractual redemption price generally equals trust assets, including retained interest, divided by outstanding public shares. Interest can be withdrawn to pay taxes and permitted working-capital expenses, with working-capital withdrawals capped at $1 million annually plus permitted rollovers. On liquidation, up to $100,000 of interest may also fund dissolution expenses. Public shareholders can redeem in connection with an eligible business combination, specified charter amendments or liquidation; they cannot demand immediate redemption merely because the market price is below trust value. INFERENCE: At $9.83, a $10.00 redemption would produce $0.17 per share before brokerage costs, taxes and the time value of money. Future retained interest could increase redemption proceeds, but the October 27 trust balance is not independently verified at $10.00 per share. Redemption proceeds remain subject to applicable law, creditor claims and procedural requirements. This is not an unconditional guaranteed floor.

Capital structure, founder promote and warrant dilutionIPHX has 28,750,000 public Class A shares, 9,583,333 sponsor-held Class B founder shares, 9,583,333 public warrants and 8,000,000 private-placement warrants. The substantial founder promote and warrant overhang create meaningful post-merger dilution risk.

FACTS: The August 31 audited balance sheet confirms 28.75 million public shares and 9.583333 million Class B founder shares. The sponsor's October 19 Schedule 13G reports beneficial ownership equivalent to 25% of the 38,333,333-share pre-warrant capitalization on an as-converted basis. These 9.583333 million potentially convertible Class A shares are the existing Class B founder shares, not additional public shares. Public units generated approximately 9.583333 million whole warrants, and the private placement generated 8 million warrants, split between the sponsor (5 million) and Cohen & Company Capital Markets (3 million). Each whole warrant generally permits the purchase of one Class A share at $11.50, subject to adjustment, beginning 30 days after a completed business combination. Public warrants are not redeemable for trust cash and can expire worthless if no merger occurs. Founder shares generally convert one-for-one but carry an anti-dilution adjustment that can preserve a 25% promote calculation in certain additional-equity issuance scenarios. The company also reported $13.6875 million of deferred underwriting fees, payable from remaining trust proceeds after properly submitted redemptions upon a completed business combination. INFERENCE: The 17.583333 million outstanding warrants represent potential issuance equal to approximately 61.2% of the original public-share count if all were exercised for one share each. Actual dilution depends on merger terms, exercises, cashless mechanisms, redemptions and additional financing. It affects investors who retain shares after a merger rather than directly reducing a properly exercised pre-merger redemption entitlement.

Combination deadline, progress and valuation judgmentThe contractual 24-month completion window runs from August 31, 2026 to approximately August 31, 2028, subject to an earlier board-approved liquidation or subsequent lawful amendments. The modest discount to trust value supports a Fair-priced verdict rather than a compelling undervaluation.

FACTS: The audited August 31 financial statements specify a 24-month completion period, with liquidation redemption generally occurring within ten business days after expiration if no combination closes. The sponsor's founder shares waive liquidating distributions from the trust. The September 30 announcement concerns separate securities trading, not an acquisition agreement. The October 19 ownership filing discloses existing beneficial ownership, not a merger. An affiliated investment fund expressed an intention to provide a potential $25 million PIPE investment, but this remains subject to investment-committee approval, diligence and negotiated transaction terms; it is not committed merger financing. INFERENCE: From October 27, 2026, the ordinary deadline is about 22 months away. The $0.17 discount to the last audited initial trust value offers limited immediate margin after considering time, execution costs, opportunity cost and potentially thin trading liquidity. A target announcement could accelerate access to redemption but might also introduce a volatile post-merger valuation. Additional risks include failed negotiations, extensions or earlier liquidation, trust withdrawals, creditor claims, sponsor incentives, trading spreads and substantial post-merger dilution. The $9.83 quotation is a Cboe BZX real-time estimate rather than a guaranteed executable offer. Fair-priced is a qualitative, redemption-based assessment, not a forecast or appraisal of an unidentified future operating business.

AI: News

October 19, 2026 — Sponsor discloses 25% beneficial ownershipInflection Point Holdings VIII LLC, Inflection Point Asset Management LLC and Michael Blitzer filed a Schedule 13G reporting beneficial ownership of 9,583,333 Class A shares on an as-converted basis, representing 25.0%.

FACTS: The October 19, 2026 SEC filing identifies Inflection Point Holdings VIII LLC as record holder, Inflection Point Asset Management LLC as manager and Michael Blitzer as the controlling investment decision-maker. The reported 9,583,333 shares represent Class A shares issuable upon conversion of 9,583,333 existing Class B founder shares. The denominator is 38,333,333 shares, consisting of 28,750,000 outstanding public Class A shares plus the founder-share conversion amount. The filing specifies September 30, 2026 as the event date requiring disclosure. INFERENCE: The disclosure confirms concentrated sponsor control and a substantial founder promote, but is not evidence of newly purchased shares, a fresh capital injection or an announced acquisition. It highlights governance and dilution considerations for potential post-merger holders.

September 30, 2026 — Class A shares and warrants cleared for separate tradingThe issuer announced that its IPO units could be separated beginning on or about October 5, 2026, establishing standalone Nasdaq trading under IPHX and IPHXW while existing units continued under IPHXU.

FACTS: The company-issued September 30 press release, attached to its SEC Form 8-K and distributed through Nasdaq, confirms that each IPO unit contains one Class A ordinary share and one-third of a redeemable warrant. Only whole warrants can trade separately; fractional warrants are not issued. Unit holders seeking separation must work through their brokers and Continental Stock Transfer & Trust Company. The release reiterates the company's intention to seek North American or European businesses in disruptive growth sectors, without limiting its permissible geographic or sector focus. INFERENCE: Separate trading improves the ability to value and transact in the cash-backed Class A shares independently from warrant speculation. It does not itself establish progress toward a signed business combination.

Loading local price history

Revenue

No reported data

Net income

No reported data

Free cash flow

No reported data

Total cash / debt

CashTotal debt

No reported data

Financial statements

No quarterly filing data is available.

Review official source filings ↗

Owners

Reported shareholders

Ownership data is not available for this listing yet.

Insider buys & sells

Oct 1, 2024–Sep 30, 2026

Buys0$0.00 disclosed value

Sells (SEC code S)0$0.00 disclosed value

No insider transactions transactions were reported in the stored SEC coverage.

Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about IPHX yet. Start the conversation.

Write the first post

Inflection Point Acquisition Corp. VIII (IPHX)

Financial charts

Financial statements

Owners

Insider buys & sells

Community posts

It’s quiet here.